3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
4
Wounds and Injuries
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Pain
1
Nasopharyngeal Carcinoma
1
Carcinoma, Squamous Cell
1
Cancer Pain
1
Breast Neoplasms
1
Breakthrough Pain
1
Agnosia
1
Interventions
Morphine
1
Gastrostomy
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breakthrough Pain
×
Morphine
×
Head & Neck
×
Clear all
NCT02869321
2019-05-13
ANTALGIP
Central Hospital, Nancy, France
Phase 4
Completed
20 enrolled